MTOR and neuroblastoma: Treatment with IBL‐202 and IBL‐301 reduced cell viability in two PDX lines and two conventional neuroblastoma cell lines, and the triple PIM/PI3K/mTOR inhibitor IBL‐301 had distinctly lower GI50 (Fig 4A and Appendix Table S2).